Follow The Filings

CLVT Clarivate

Clarivate earnings company data as of 4:47 AM ET 9/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 0.16 — —
Rev — — —

Insider trades

Open-market buys and sales by CLVT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CLVT insider trades
  • $9.4M bought by 2 insiders
  • $4.8M sold by 1 insider outside a trading plan
  • $1.2M sold by 1 insider under 10b5-1 plans
  1. Kenneth L. Cornick Director
    Buy
    $1.7M 900,000 shares at $1.86 +82% to stake
    Traded Aug 6–7 Filed Aug 10
  2. Andrew Miles Snyder Director
    Sale
    $4.8M 2,489,618 shares at $1.94 27% of stake
    Traded Aug 3 Filed Aug 5
  3. Bar Veinstein President, A&G
    Planned sale
    $1.2M 309,902 shares at $3.74 27% of stake
    Traded Dec 1, 2025 Filed Dec 2, 2025
  4. Kenneth L. Cornick Director
    Buy
    $345K 100,000 shares at $3.45 +10% to stake
    Traded Nov 10, 2025 Filed Nov 13, 2025
  5. Kenneth L. Cornick Director
    Buy
    $2.5M 725,000 shares at $3.42 +264% to stake
    Traded Oct 31, 2025–Nov 3, 2025 Filed Nov 3, 2025
  6. Andrew Miles Snyder Director
    Buy
    $4.9M 1,460,000 shares at $3.33 +185% to stake
    Traded Oct 31, 2025 Filed Nov 3, 2025

Also filed in the last 12 months, not counted as buying or selling: 37 share withholdings for taxes, 35 stock grants, 1 gift, and 1 other transaction.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
8-K/A 2.01,9.01
8-K 2.01,5.02,8.01,9.01
8-K 8.01,9.01
8-K 8.01,9.01
8-K 8.01,9.01
8-K 2.02,7.01,9.01
10-Q
8-K 5.02,7.01,9.01
8-K 7.01,9.01
8-K 1.01,5.02,9.01
8-K 5.02,7.01,9.01
8-K 5.07,8.01
SCHEDULE 13G/A —
8-K 2.02,7.01,9.01
10-Q
DEF 14A
DEFA14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.